Online Inquiry
  •  

Human M2 Macrophage Differentiation Kit (MTS-1123-HM121)

Overview

Description
This product harvests CD14+ monocytes from peripheral blood mononuclear cells and drives their differentiation ex vivo which can provide an abundant source of M2 macrophages for downstream research studies.
Applications
ELISA
Features
Utilizes validated and straightforward procedures; Does not require specialized instrumentation
Qualified With
Quality Certificate
Species
Human CD14+ monocytes

Specification

Size
1 Kit
Storage
-20 °C
Storage Comment
Reference to the protocol
Expiry Date
3 months
Product Disclaimer
This product is provided for research only, not suitable for human or animal use.
FAQs Customer Reviews Related Products

Does this kit start from PBMCs or purified monocytes, and what's the main advantage if my lab doesn't have specialized equipment?

The kit is designed around harvesting CD14+ monocytes from peripheral blood mononuclear cells (PBMCs) and driving ex vivo differentiation to provide an abundant source of M2 macrophages for downstream studies. A key benefit is operational simplicity: it uses validated, straightforward procedures and does not require specialized instrumentation. Practically, that means most standard cell culture labs can implement it with common equipment (biosafety cabinet, incubator, centrifuge). If you start with PBMCs, you can incorporate your preferred CD14+ enrichment approach, then follow the kit's differentiation steps to standardize polarization outcomes.

How should I confirm that the cells are truly M2-like and not mixed phenotypes, especially when comparing donors?

For M2 confirmation, we recommend a multi-layer validation plan: (1) surface markers commonly associated with M2-like macrophages (e.g., CD206, CD163) measured by flow cytometry; (2) cytokine profile checks (e.g., higher IL-10 relative to pro-inflammatory cytokines under relevant stimulation); and (3) functional assays aligned to your biology (wound-healing migration cues, phagocytosis changes, or T-cell modulation readouts). Since donor variability can be substantial, build acceptance criteria (marker thresholds and morphology notes) and always include an M0-like baseline and a pro-inflammatory comparator. This approach helps you interpret donor effects versus kit performance and improves reproducibility across studies.

What are storage and stability constraints? We often need to stagger experiments across a quarter.

The kit specification lists a storage temperature of -20 °C and an expiry date of 3 months, with storage guidance referencing the protocol. To support staggered experiments, plan your run calendar so all differentiations occur within the shelf-life window and minimize repeated freeze-thaw exposure by aliquoting components when permitted by the protocol. Also, standardize your monocyte input (cell number, viability, and isolation method) and keep a small batch of QC readouts (marker flow panels or qPCR checks) so you can confirm lot-to-lot and time-based consistency. If your timeline is longer than three months, consider ordering in phases.

  • Simple workflow produced consistent M2-like morphology across donors
    We needed a reliable way to generate M2-like macrophages from PBMC donors without over-engineering the protocol. This kit fit well because the steps were straightforward and didn't demand specialized instrumentation. We validated M2-like outcomes using flow markers and IL-10-skewed secretion after stimulation, and the results were consistent enough to compare donors in a small cohort study. The biggest practical win was time: fewer troubleshooting cycles and less variability from ad hoc cytokine mixing. We'd recommend it to teams building macrophage assays for the first time.
  • Good standardization for downstream tumor microenvironment co-culture assays
    Our application was tumor spheroid co-culture, where macrophage polarization state heavily influences readouts. The kit generated an abundant M2 macrophage source for our experiments as described. We appreciated the predictable differentiation performance, which let us focus on the biology rather than media composition optimization. Storage and scheduling needed attention because of the three-month expiry, so we aligned donor collection accordingly. Once we implemented a simple QC panel (CD206/CD163 plus cytokines), the workflow became a dependable part of our pipeline.
  • Reliable differentiation when PBMC quality varies, with sensible protocol guidance
    PBMC quality can be variable in our setting, so we wanted a kit that would reduce the number of moving parts. The protocol-driven approach helped us standardize density, feeding schedule, and timing, which improved repeatability. We still saw donor-to-donor differences (expected), but the overall M2-like direction was clear when we applied consistent acceptance criteria. The kit also fit nicely into a weekly cadence: isolate/enrich, differentiate, QC, then proceed into functional assays. It's not a substitute for good cell handling, but it definitely lowered our failure rate.

For Research Use Only. Do Not Use in Food Manufacturing or Medical Procedures (Diagnostics or Therapeutics). Do Not Use in Humans.

CONTACT US
()
()
()
ADDRESS


> Global

ISO 9001 Certified - Creative Biolabs Quality Management System.

Copyright © 2026 Creative Biolabs. All Rights Reserved.